108 related articles for article (PubMed ID: 12173063)
1. [The expression of zeta-chain of the T cell receptor as prognostic marker for patients with head and neck cancer].
Müller D; Lang S; Roskrow M; Wollenberg B
Laryngorhinootologie; 2002 Jul; 81(7):516-20. PubMed ID: 12173063
[TBL] [Abstract][Full Text] [Related]
2. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
[TBL] [Abstract][Full Text] [Related]
3. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma.
Reichert TE; Scheuer C; Day R; Wagner W; Whiteside TL
Cancer; 2001 Jun; 91(11):2136-47. PubMed ID: 11391595
[TBL] [Abstract][Full Text] [Related]
4. Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma.
Reichert TE; Day R; Wagner EM; Whiteside TL
Cancer Res; 1998 Dec; 58(23):5344-7. PubMed ID: 9850063
[TBL] [Abstract][Full Text] [Related]
5. T-cell receptor zeta-chain expression on tumor-infiltrating lymphocytes from renal cell carcinoma.
Cardi G; Heaney JA; Schned AR; Phillips DM; Branda MT; Ernstoff MS
Cancer Res; 1997 Aug; 57(16):3517-9. PubMed ID: 9270022
[TBL] [Abstract][Full Text] [Related]
6. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
Cole DJ; Wilson MC; Rivoltini L; Custer M; Nishimura MI
Cancer Res; 1997 Dec; 57(23):5320-7. PubMed ID: 9393756
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer.
Kuss I; Saito T; Johnson JT; Whiteside TL
Clin Cancer Res; 1999 Feb; 5(2):329-34. PubMed ID: 10037182
[TBL] [Abstract][Full Text] [Related]
8. Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck.
Bas M; Bier H; Schirlau K; Friebe-Hoffmann U; Scheckenbach K; Balz V; Whiteside TL; Hoffmann TK
Oral Oncol; 2006 Aug; 42(7):691-7. PubMed ID: 16527515
[TBL] [Abstract][Full Text] [Related]
9. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
10. Loss of T-cell receptor-CD3zeta and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinoma.
Lockhart DC; Chan AK; Mak S; Joo HG; Daust HA; Carritte A; Douville CC; Goedegebuure PS; Eberlein TJ
Surgery; 2001 Jun; 129(6):749-56. PubMed ID: 11391375
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer.
Kono K; Ressing ME; Brandt RM; Melief CJ; Potkul RK; Andersson B; Petersson M; Kast WM; Kiessling R
Clin Cancer Res; 1996 Nov; 2(11):1825-8. PubMed ID: 9816136
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma.
Nakagomi H; Petersson M; Magnusson I; Juhlin C; Matsuda M; Mellstedt H; Taupin JL; Vivier E; Anderson P; Kiessling R
Cancer Res; 1993 Dec; 53(23):5610-2. PubMed ID: 8242612
[TBL] [Abstract][Full Text] [Related]
13. [Quantitative changes in the immunoglobulin G subclass system--a reliable tumor marker in squamous epithelial carcinoma in the area of the head-neck].
Anderhuber W; Steinschifter W; Gotschuli A; Schauenstein E; Schauenstein K
Laryngorhinootologie; 1998 Oct; 77(10):564-8. PubMed ID: 9842520
[TBL] [Abstract][Full Text] [Related]
14. Elevated caspase-3 activity in peripheral blood T cells coexists with increased degree of T-cell apoptosis and down-regulation of TCR zeta molecules in patients with gastric cancer.
Takahashi A; Kono K; Amemiya H; Iizuka H; Fujii H; Matsumoto Y
Clin Cancer Res; 2001 Jan; 7(1):74-80. PubMed ID: 11205921
[TBL] [Abstract][Full Text] [Related]
15. The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.
Weidmann E; Whiteside TL; Giorda R; Herberman RB; Trucco M
Cancer Res; 1992 Nov; 52(21):5913-20. PubMed ID: 1382847
[TBL] [Abstract][Full Text] [Related]
16. Tumor antigen phenotype, biologic staging, and prognosis in head and neck squamous carcinoma.
Wolf GT; Carey TE
J Natl Cancer Inst Monogr; 1992; (13):67-74. PubMed ID: 1389697
[TBL] [Abstract][Full Text] [Related]
17. Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma.
Finke JH; Zea AH; Stanley J; Longo DL; Mizoguchi H; Tubbs RR; Wiltrout RH; O'Shea JJ; Kudoh S; Klein E
Cancer Res; 1993 Dec; 53(23):5613-6. PubMed ID: 8242613
[TBL] [Abstract][Full Text] [Related]
18. MHC-class I antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer.
Andratschke M; Pauli C; Stein M; Chaubal S; Wollenberg B
Anticancer Res; 2003; 23(2B):1467-71. PubMed ID: 12820411
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the T-cell receptor variable beta gene-restricted profile of CD8+ T lymphocytes in the peripheral circulation of patients with squamous cell carcinoma of the head and neck.
Albers AE; Visus C; Tsukishiro T; Ferris RL; Gooding W; Whiteside TL; De Leo AB
Clin Cancer Res; 2006 Apr; 12(8):2394-403. PubMed ID: 16638844
[TBL] [Abstract][Full Text] [Related]
20. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease.
Matsuda M; Petersson M; Lenkei R; Taupin JL; Magnusson I; Mellstedt H; Anderson P; Kiessling R
Int J Cancer; 1995 Jun; 61(6):765-72. PubMed ID: 7790109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
